glycolic acid cyclohexyl ester | 71138-82-4

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: glycolic acid cyclohexyl ester
• 英文别名: Glykolsaeure-cyclohexylester；Glykoloyloxy-cyclohexan；Cyclohexyl hydroxyacetate；cyclohexyl 2-hydroxyacetate
• CAS: 71138-82-4
• 化学式: C₈H₁₄O₃
• 分子量: 158.197
• InChiKey: SYNLVXCQXYVPOA-UHFFFAOYSA-N

物化性质

• 沸点：
  244.8±13.0 °C(Predicted)
• 密度：
  1.09±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] SYNTHESIS OF GLYCOLS VIA TRANSFER HYDROGENATION OF ALPHA-FUNCTIONAL ESTERS WITH ALCOHOLS<br/>[FR] SYNTHÈSE DE GLYCOLS AU MOYEN D'UNE HYDROGÉNATION PAR TRANSFERT D'ESTERS ALPHA-FONCTIONNELS AVEC DES ALCOOLS
  申请人：EASTMAN CHEM CO

  公开号：WO2019027948A1

  公开（公告）日：2019-02-07

  A transfer hydrogenation process for forming vicinal diols by hydrogenating 1,2-dioxygenated organic compounds using alcohols as the reducing agent instead of the traditional H2 gas. The transfer hydrogenation is carried out under milder conditions of temperature and pressure than is typical for ester hydrogenation with H2. The milder conditions of operation provide benefits, such as lower operating and capital costs for industrial scale production as well as savings in product purification due to the avoidance of by-products from exposure of reaction mixtures and products to high temperatures.

  一种通过使用醇作为还原剂而不是传统的氢气，在较温和的温度和压力条件下，通过氢化1,2-二氧化有机化合物形成邻二醇的转移加氢过程。操作的较温和条件提供了诸如工业规模生产的较低运营和资本成本以及由于避免将反应混合物和产物暴露在高温下而节省产品纯化成本的好处。
• N-ACYL-B-LACTAM DERIVATIVE, MACROMOLECULAR COMPOUND, AND PHOTORESIST COMPOSITION
  申请人：Fukumoto Takashi

  公开号：US20120148954A1

  公开（公告）日：2012-06-14

  Disclosed are an N-acyl-β-lactam derivative represented by the following general formula, from which a photoresist composition capable of controlling an acid diffusion length to be short is obtained; a polymer obtained by polymerizing the N-acyl-β-lactam derivative represented by the following general formula as one of starting materials; and a photoresist composition containing the polymer. In the formula, R 1 represents a hydrogen atom, a methyl group, or a trifluoromethyl group; W represents an alkylene group or a cycloalkylene group; n represents 0 or 1; and each of R 2 , R 3 , R 4 , and R 5 independently represents a hydrogen atom, an alkyl group, a cyclic hydrocarbon group, or an acyloxy group, provided that 1) R 2 and R 3 , or R 4 and R 5 , may be connected to each other to form a substituted or unsubstituted ring which may have an oxygen atom at an arbitrary position, 2) R 3 and R 4 may be connected to each other to form a substituted or unsubstituted ring which may have an oxygen atom at an arbitrary position, and 3) all of R 2 , R 3 , R 4 , and R 5 are not a hydrogen atom at the same time.

  本公开了一种N-酰基-β-内酰胺衍生物，其由以下通用式表示，从中可以获得一种能够控制酸扩散长度较短的光刻胶组合物；一种由将以下通用式表示的N-酰基-β-内酰胺衍生物聚合而成的聚合物作为起始材料之一；以及含有该聚合物的光刻胶组合物。在该式中，R1代表氢原子、甲基或三氟甲基基团；W代表烷基基团或环烷基基团；n代表0或1；而R2、R3、R4和R5中的每一个独立地代表氢原子、烷基基团、环烃基团或酰氧基团，前提是1）R2和R3，或R4和R5，可以连接在一起形成一个取代或未取代的环，该环在任意位置可能有一个氧原子，2）R3和R4可以连接在一起形成一个取代或未取代的环，该环在任意位置可能有一个氧原子，3）R2、R3、R4和R5中的所有基团不同时为氢原子。
• PERFUME
  申请人：Hölscher Bernd

  公开号：US20130261036A1

  公开（公告）日：2013-10-03

  The present invention relates to perfumes of general formula (A) It further relates to the use of the compounds of formula (A) for imparting or intensifying particular odor notes and/or particular odor impressions and a method of producing a perfume mixture or a perfumed product.

  本发明涉及一般式（A）的香水。它还涉及使用式（A）的化合物赋予或强化特定的气味音符和/或特定的气味印象，以及制备香水混合物或带香气的产品的方法。
• METHODS FOR MODIFYING 1,3,5-TRIAZINE DERIVATIVES
  申请人：NISSAN CHEMICAL INDUSTRIES, LIMITED

  公开号：EP0882720A1

  公开（公告）日：1998-12-09

  A method for modifying 1,3,5-triazine derivatives characterized by reacting a 1,3,5-triazine derivative having at least one amino or monosubstituted amino group on any of the ring carbon atoms with an alcohol by heating in the presence of a metallic catalyst and hydrogen to thereby introduce an alkyl or alkenyl group into each amino or monosubstituted amino group; another method for modifying 1,3,5-triazine derivatives characterized by reacting a 1,3,5-triazine derivative having at least one amino or monosubstituted amino group on any of the ring carbon atoms with a dihydric alcohol by heating in the presence of a metallic catalyst and hydrogen to thereby introduce a hydroxylated alkyl group into each amino or monosubstituted amino group; and 1,3,5-triazine derivatives obtained by the methods. The various modified substituted 1,3,5-triazine derivatives thus produced are generally obtained as a mixture. These derivatives can be isolated as high-purity compounds by a general separation method for organic compounds, and the compounds are usable in the various applications mentioned in the specification. According to applications (for example, use as modifier additives, in particular a flame-retardant and a plasticizer for resins), the reaction mixture can be used as it is without being separated. Many of the substituted triazine derivatives obtained have been relatively difficult to synthesize or expensive. Since many of the derivatives are interesting with respect to their physical properties, e.g., solubility in water and in various organic solvents, high-temp. stability, melting point, boiling point, and basicity, they are thought to have a wider range of applications than conventional ones.

  一种改性 1，3，5-三嗪衍生物的方法，其特征在于在金属催化剂和氢的存在下，通过加热使任一环碳原子上具有至少一个氨基或单取代氨基的 1，3，5-三嗪衍生物与醇反应，从而在每个氨基或单取代氨基中引入一个烷基或烯基；另一种改性 1,3,5-三嗪衍生物的方法，其特征在于在金属催化剂和氢气存在下，使任一环碳原子上具有至少一个氨基或单取代氨基的 1,3,5-三嗪衍生物与二元醇反应，从而在每个氨基或单取代氨基中引入羟基烷基；以及通过上述方法获得的 1,3,5-三嗪衍生物。这样制得的各种改性取代的 1,3,5-三嗪衍生物通常以混合物的形式获得。这些衍生物可作为高纯度化合物通过有机化合物的一般分离方法分离出来，这些化合物可用于说明书中提到的各种应用中。根据用途（例如用作改性添加剂，特别是阻燃剂和树脂增塑剂），反应混合物可以不经分离直接使用。所获得的许多取代三嗪衍生物都比较难以合成或价格昂贵。由于许多衍生物在物理性质（如在水和各种有机溶剂中的溶解性、高温稳定性、熔点、沸点和碱性）方面都很有趣，因此它们被认为比传统的衍生物具有更广泛的用途。
• THERAPEUTIC AGENT FOR ERECTION FAILURE
  申请人：MOCHIDA PHARMACEUTICAL CO., LTD.

  公开号：EP0992240A1

  公开（公告）日：2000-04-12

  A therapeutic agent for erection dysfunction and gynecoid incompetence, which is free from the problems involved in oral administration and direct injection, is safe, and exhibits excellent effect. A therapeutic agent for erection dysfunction and gynecoid incompetence for intranasal administration, percutaneous administration, or mucosal administration, such as oral mucosal administration or penis mucosal administration, characterized by containing as the active ingredient at least one compound having cyclic GMP phosphodiesterase inhibitory activity or salt thereof.

  一种治疗勃起功能障碍和妇科功能不全的药剂，它没有口服给药和直接注射给药的问题，安全且效果极佳。一种用于鼻内给药、经皮给药或粘膜给药（如口腔粘膜给药、阴茎粘膜给药）的勃起功能障碍和妇科功能不全治疗剂，其特征在于活性成分中至少含有一种具有环 GMP 磷酸二酯酶抑制活性的化合物或其盐。